Sam Chun Dang Pharm. Co., Ltd
000250
Rangering i aksjer
#4333
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and... Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
Aksjekurs
$152.58
Markedsverdi
$3.57B
Endring (1 dag)
3.84%
Endring (1 år)
6.02%
Land
KR
Handel Sam Chun Dang Pharm. Co., Ltd (000250)
Kategori
Healthcare
P/B-forhold for Sam Chun Dang Pharm. Co., Ltd (000250)
P/B-forhold per October 2026 TTM: 15.52
Ifølge Sam Chun Dang Pharm. Co., Ltd sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 15.52. Ved slutten av 2024 hadde selskapet et P/B-forhold på 12.84.
P/B-historikk for Sam Chun Dang Pharm. Co., Ltd fra 2012 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 15.52 | -21.47% |
| 2025 | 19.76 | 53.83% |
| 2024 | 12.84 | 58.07% |
| 2023 | 8.13 | 49.29% |
| 2022 | 5.44 | -0.95% |
| 2021 | 5.50 | -42.35% |
| 2020 | 9.53 | 97.46% |
| 2019 | 4.83 | -8.87% |
| 2018 | 5.30 | 90.22% |
| 2017 | 2.78 | 42.60% |
| 2016 | 1.95 | 19.20% |
| 2015 | 1.64 | -14.91% |
| 2014 | 1.93 | 100.16% |
| 2013 | 0.96 | 47.63% |
| 2012 | 0.65 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 4.1075 | -73.53% |
US
|
|
| 3.7025 | -76.14% |
SE
|
|
| 2.6828 | -82.71% |
FR
|
|
| 5.055 | -67.42% |
IT
|
|
| 17.3614 | 11.88% |
US
|
